Marker Therapeutics Chair Frederick Wasserman to not stand for reelection at 2022 Annual Meeting

Marker Therapeutics, Inc.

Frederick Wasserman, Chair of the Board, will not stand for reelection at the 2022 Annual Meeting.
He has served on the Board since January 2016 and will continue in his roles until the meeting conclusion.
His decision is not based on any disagreement with the Company or its management.
No replacement for the Chair or director position has been announced yet.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Frederick Wasserman

Chair of the Board

MRKR · Marker Therapeutics, Inc.

Filed: April 6, 2022, 7:59 PM ET

On April 5, 2022, Mr. Frederick Wasserman, a member of the board of directors (the “Board”) of Marker Therapeutics, Inc. (the “Company”), notified the Board that he will not stand for reelection as a director of the Company upon expiration of his current term.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Frederick Wasserman departed as Chair of the Board at Marker Therapeutics, Inc..

Action: will not stand for reelection
Role: Chair of the Board

Exact text from the filing

On April 5, 2022, Mr. Frederick Wasserman, a member of the board of directors (the “Board”) of Marker Therapeutics, Inc. (the “Company”), notified the Board that he will not stand for reelection as a director of the Company upon expiration of his current term.

View on SEC.gov

Marker Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-043215

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.